Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Patient knowledge regarding tardive dyskinesia].

E M Haberfellner1, H Rittmannsberger

  • 1e.m.haberfellner@aon.at

Der Nervenarzt
|March 23, 2006
PubMed
Summary

Patients with schizophrenia have low awareness of tardive dyskinesia (TD) risks from antipsychotics. Providing clear oral information significantly improves patient understanding of TD in the short term.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and tolerability of quetiapine in patients with schizophrenia switched from other antipsychotics.

International journal of psychiatry in clinical practice·2014
Same author

[Medical rehabilitation of patients with mental or psychosomatic disorders in austria--findings of a catamnestic study].

Die Rehabilitation·2008
Same author

A review of the assessment of antidepressant-induced sexual dysfunction used in randomized, controlled clinical trials.

Pharmacopsychiatry·2007
Same author

Priapism with sertraline-risperidone combination.

Pharmacopsychiatry·2007
Same author

Spontaneous remission of SSRI-induced orgasm delay.

Pharmacopsychiatry·2004
Same author

Polypharmacy in psychiatric inpatient treatment.

The American journal of psychiatry·2004

Area of Science:

  • Psychiatry
  • Neurology
  • Pharmacology

Context:

  • Informed consent for antipsychotic treatment requires patient understanding of tardive dyskinesia (TD) risks.
  • Patient education on TD is crucial for valid consent and treatment adherence.

Purpose:

  • To assess the baseline knowledge of TD in patients treated with antipsychotics.
  • To evaluate the effectiveness of providing additional oral information on TD.
  • To identify factors influencing patient comprehension of TD risks.

Summary:

  • Initially, only 17% of patients were informed about TD, despite reading leaflets or prior information.
  • After receiving targeted oral information, 72% of patients became informed about TD.
  • Elderly patients and those with severe psychopathology were less likely to be informed.

Impact:

  • Oral information significantly enhances patient knowledge of TD risks associated with antipsychotic medications.
  • Improved patient understanding can lead to more informed treatment decisions and potentially better outcomes.
  • This highlights the need for effective communication strategies in psychiatric care regarding medication side effects.

Related Experiment Videos